StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) stock

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3090% above fair value
$294.55−0.48 (-0.16%)

Close on Nov 16, 2026Market cap $520.50BP/E 83.2Yield 2.26%

AbbVie enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

AbbVie's enterprise value was $587.37B on Nov 11, 2026, against $466.77B a year earlier. Over the last 5 years it ranged from $294.85B to $587.37B, with a median of $369.47B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$587.37B+25.5%
2025Dec 31, 2025$468.17B+23.6%
2024Dec 31, 2024$378.90B+17.5%
2023Dec 29, 2023$322.52B-6.5%
2022Dec 30, 2022$345.02B+11.6%
2021Dec 31, 2021$309.14B+23.5%
2020Dec 31, 2020$250.35B+57.0%
2019Dec 31, 2019$159.48B-9.7%
2018Dec 31, 2018$176.67B-3.8%
2017Dec 29, 2017$183.73B+39.5%
2016Dec 30, 2016$131.74B+10.3%
2015Dec 31, 2015$119.41B+6.3%
2014Dec 31, 2014$112.37B+25.3%
2013Dec 31, 2013$89.66B–

More AbbVie figures

See a number that looks wrong?